CVS Health Corporation
CVS
$76.73
$0.040.05%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.87% | 4.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.87% | 4.63% | |||
| Cost of Revenue | 4.39% | 6.40% | |||
| Gross Profit | 0.52% | -5.55% | |||
| SG&A Expenses | 8.03% | -2.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.78% | 5.39% | |||
| Operating Income | -27.65% | -16.19% | |||
| Income Before Tax | -311.41% | -37.07% | |||
| Income Tax Expenses | -19.87% | -24.07% | |||
| Earnings from Continuing Operations | -493.88% | -43.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 87.50% | 366.67% | |||
| Net Income | -489.32% | -42.61% | |||
| EBIT | -27.65% | -16.19% | |||
| EBITDA | -20.36% | -11.61% | |||
| EPS Basic | -488.39% | -42.83% | |||
| Normalized Basic EPS | -25.16% | -17.56% | |||
| EPS Diluted | -491.55% | -43.26% | |||
| Normalized Diluted EPS | -24.93% | -17.62% | |||
| Average Basic Shares Outstanding | 0.24% | 0.40% | |||
| Average Diluted Shares Outstanding | -0.08% | 0.47% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -1.25% | 0.80% | |||